(Press-News.org) CROWN POINT, Ind. — OYE Therapeutics Inc., a privately held biopharmaceutical company developing first-in-class intravenous caffeine-based therapies for anesthesia recovery and opioid-induced respiratory depression, has announced the successful close of its $5 million convertible note financing, positioning the company to enter clinical development.
The company is headquartered at the Purdue Technology Center of Northwest Indiana.
CEO Brett Dines said the round drew strong new investor participation and was oversubscribed to $5.6 million, reflecting sustained confidence across OYE’s investor base.
Advancing to the clinic
Proceeds from the raise will support OYE’s Phase 1 pharmacokinetic and safety study and its subsequent pivotal trials. This dataset will be leveraged across all investigational new drugs (INDs), enabling an accelerated multitrack clinical program.
Dines said closing the round marks a transformative moment for the company.
“The confidence shown by our investors underscores the strength of our science and our mission,” he said. “With this financing, we are well positioned to enter the clinic and generate meaningful clinical data.”
Looking ahead
OYE anticipates sharing top-line clinical results in 2026, a key milestone expected to expand engagement with strategic and financial partners across the health care sector.
Dines said moving into the clinical stage is a defining moment for the company and its technology.
“We look forward to demonstrating the potential of our therapy in several prospective pivotal studies to improve anesthesia recovery and address opioid-induced respiratory depression in both hospital and emergency care settings,” he said.
About OYE Therapeutics
OYE Therapeutics Inc. is a biopharmaceutical company based at the Purdue Technology Center of Northwest Indiana developing intravenous caffeine-based therapies intended to reverse general anesthesia, sedation and opioid-induced respiratory depression. Supported by public and private investment, OYE’s programs aim to address significant unmet needs in perioperative and acute care medicine.
Media Contact: Michael Hicks, Chief Operating Officer, mhicks@oyetherapeutics.com, 219-281-2369
END
OYE Therapeutics closes $5M convertible note round, advancing toward clinical development
2025-12-05
ELSE PRESS RELEASES FROM THIS DATE:
Membrane ‘neighborhood’ helps transporter protein regulate cell signaling
2025-12-05
(MEMPHIS, Tenn. – December 5, 2025) When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ensure the signal reaches the correct effector without triggering pathways accidentally, cAMP levels must be maintained around their point of origin and at the right level. ABCC4, a protein that transports cAMP out of cells and also contributes to drug resistance, helps with this local control. Yet, how ABCC4 is held in place at the right spot to perform these functions was not clear. Scientists at St. Jude Children’s Research Hospital revealed that global elevation ...
Naval aviator turned NPS doctoral student earns national recognition for applied quantum research
2025-12-05
A Naval Postgraduate School (NPS) physics doctoral student has just been presented with a prestigious award for his pioneering research in quantum sensing using a unique atomic fountain.
U.S. Navy Cmdr. Jens Berdahl, a former naval aviator and F/A-18 pilot currently pursuing his doctorate through the service’s Permanent Military Professor (PMP) program, was recently presented with the highly competitive Margaret Burbidge Award for Best Experimental Research by a Graduate Student. Presented by the American Physical Society, Far West Section, Berdahl received the award while presenting his research on NPS’s ...
Astronomers watch stars explode in real time through new images
2025-12-05
Astronomers have captured unprecedented, detailed images of two stellar explosions—known as novae—within days of their eruption. The breakthrough provides direct evidence that these explosions are more complex than previously thought, with multiple outflows of material and, in some cases, dramatic delays in the ejection process.
The international study, published in Nature Astronomy, used a cutting-edge technique called interferometry at the Center for High Angular Resolution Astronomy, or CHARA, Array in California. This approach allowed scientists, including Michigan State University researcher Laura Chomiuk, to combine the light from multiple ...
Carbon-negative building material developed at Worcester Polytechnic Institute published in matter
2025-12-05
Worcester Polytechnic Institute (WPI) researchers have created a new carbon-negative building material that could transform sustainable construction. The breakthrough, published in the high-impact journal Matter, details the development of enzymatic structural material (ESM), a strong, durable, and recyclable construction material produced through a low-energy, bioinspired process.
Led by Nima Rahbar, the Ralph H. White Family Distinguished Professor and head of the Department of Civil, Environmental, and Architectural Engineering, the research team engineered ESM by using an enzyme that helps convert carbon dioxide into solid mineral particles. ...
Free radicals caught in the act with slow spectroscopy
2025-12-05
Why does plastic turn brittle and paint fade when exposed to the sun for long periods? Scientists have long known that such organic photodegradation occurs due to the sun’s energy generating free radicals: molecules that have lost an electron to sunlight-induced ionization and have been left with an unpaired one, making them very eager to react with other molecules in the environment. However, the exact mechanisms for how and why the energy from the sun’s photons get stored and released in the materials over very long ...
New research highlights Syntax Bio’s platform for simple yet powerful programming of human stem cells
2025-12-05
***Under strict embargo until 14:00 (2:00 pm) U.S. Eastern Time Friday, 05 December 2025 ***
FOR IMMEDIATE RELEASE
New Research Highlights Syntax Bio’s Platform for Simple Yet Powerful Programming of Human Stem Cells
The Science Advances publication details Cellgorithm™, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell programming for research and therapeutic development.
CHICAGO, Dec. 8, 2025 – Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing ...
Researchers from the HSE University investigated reading in adolescents
2025-12-05
Psycholinguists from the Center for Language and Brain found that phonological processing skills continue to influence text reading fluency in 15-to-18-year-old adolescents. This finding argues the long-held belief that in this age group the phonological processing skills are not involved in reading. The study was published in PLOS One.
Phoneme – is the smallest phonetic unit that helps to distinguish one word from another. Previously, it was stated that phonological processing skills (i.e., the ability to operate with phonemes) are required for early stages of reading development. However, researchers from the Center for Language and ...
Penn Nursing study: Virtual nursing programs in hospitals fall short of expectations
2025-12-05
Hospitals struggling to attract and retain enough registered nurses at the bedside are implementing alternative strategies to ensure patients get needed nursing care. This includes virtual nursing programs, a model of care in which nurses use video and messaging technologies to assess, monitor, educate, and coordinate care for hospitalized patients from an off-site location.
A new study from the Penn Nursing’s Center for Health Outcomes and Policy Research (CHOPR)—published in JAMA Network Open today—surveyed 880 in-hospital nurses about their experiences working alongside ...
Although public overwhelmingly supports hepatitis B vaccine for a newborn, partisan differences exist
2025-12-05
On December 5, 2025, the Trump administration’s Advisory Committee on Immunization Practices (ACIP), whose members were handpicked by Health and Human Services (HHS) Secretary and vaccination critic Robert F. Kennedy Jr., is scheduled to determine whether it should recommend that the Centers for Disease Control and Prevention (CDC) change the recommendation in place since 1991 that newborns be vaccinated against hepatitis B. Infection with hepatitis B can cause liver damage (cirrhosis), liver cancer, and even death. Kennedy fired the members of ACIP ...
DFW backs UTA research to bolster flood resilience
2025-12-05
The University of Texas at Arlington and Dallas Fort Worth International Airport are expanding a multi-year partnership to improve stormwater management, environmental protection and long-term operational resilience at one of the world’s busiest airports.
After completing the first phase of the project, DFW has extended its partnership with UTA’s Water Engineering Research Center (WERC) with a $2.38 million investment to build on its previous work by shifting from assessment to solutions. In total, DFW has committed more than $4 million to UTA under the interlocal agreement ...